VEGFA and aortic stenosis: Although the correlation to human or clinical data remains to be proved, it is our anticipation that the number of AS patients who are suitable for AVR will be increased, the mortality following AVR will be decreased, and postoperative recovery will be improved if VEGF pre-operative treatment can be demonstrated to be effective in clinical trials.